Identification and Functional Investigation of SOX4 as a Novel Gene Underpinning Familial Atrial Fibrillation
Diagnostics · 25.10.2024 · 14 (21) · 2376
DOI: 10.3390/diagnostics14212376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.10.2024. Verfasst von Wei-Feng Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Shanghai, China, Natural Science Foundation of Shanghai, China.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) signifies the most prevalent supraventricular arrhythmia in humans and may lead to cerebral stroke, cardiac failure, and even premature demise. Aggregating strong evidence points to genetic components as a cornerstone in the etiopathogenesis of familial AF. However, the genetic determinants for AF in most patients remain elusive.
Methods
A 4-generation pedigree with idiopathic AF and another cohort of 196 unrelated patients with idiopathic AF as well as 278 unrelated healthy volunteers were recruited from the Chinese population of Han ethnicity. A family-based whole-exome sequencing examination followed by a Sanger sequencing assay in all research subjects was implemented. The functional impacts of the identified SOX4 mutations were explored via a dual-reporter assay.
Results
Two new heterozygous SOX4 mutations, NM_003107.3: c.211C>T; p.(Gln71*) and NM_003107.3: c.290G>A; p.(Trp97*), were observed in the family and 1 of 196 patients with idiopathic AF, respectively. The two mutations were absent in the 278 control individuals. The biochemical measurements revealed that both Gln71*- and Trp97*-mutant SOX4 failed to transactivate GJA1 (Cx43). Moreover, the two mutations nullified the synergistic activation of SCN5A by SOX4 and TBX5.
Conclusions
The findings first indicate SOX4 as a gene predisposing to AF, providing a novel target for antenatal genetic screening, individualized prophylaxis, and precision treatment of AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
- Department of Cardiology, Shanghai Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Shanghai Health Development Research Center, and Shanghai Medical Information Center, Shanghai 200031, China.
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
- Department of Cardiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.
ORCID-Profile: Yi-Qing Yang
Förderung
- The Natural Science Foundation of Shanghai, China
- Natural Science Foundation of Shanghai, China
Zitieren
APA
Jiang, W. F., Sun, Y. M., Qiu, X. B., Wu, S. H., Ding, Y. Y., Li, N., Yang, C. X., Xu, Y. J., Jiang, T. B., & Yang, Y. Q. (2024). Identification and Functional Investigation of SOX4 as a Novel Gene Underpinning Familial Atrial Fibrillation. Diagnostics, 14(21), 2376. https://doi.org/10.3390/diagnostics14212376
Vancouver
Jiang WF, Sun YM, Qiu XB, Wu SH, Ding YY, Li N, et al. Identification and Functional Investigation of SOX4 as a Novel Gene Underpinning Familial Atrial Fibrillation. Diagnostics. 2024;14(21):2376. doi:10.3390/diagnostics14212376
BibTeX
@article{Jiang2024,
author = {Jiang, Wei-Feng and Sun, Yu-Min and Qiu, Xing-Biao and Wu, Shao-Hui and Ding, Yuan-Yuan and Li, Ning and Yang, Chen-Xi and Xu, Ying-Jia and Jiang, Ting-Bo and Yang, Yi-Qing},
title = {Identification and Functional Investigation of SOX4 as a Novel Gene Underpinning Familial Atrial Fibrillation},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {21},
pages = {2376},
doi = {10.3390/diagnostics14212376}
}
EUVIMED